Deferasirox is an oral iron chelator, with a long half-life, that can be given once daily, because it provides a 24-hour chelation. Several phase II trials and a pivotal phase III trial have established that, in transfusion-dependent patients with beta-thalassaemia major, deferasirox has a similar e
β¦ LIBER β¦
Antiviral Therapy: Analysis of Long-term Efficacy and Safety
β Scribed by Helen S. Te
- Book ID
- 107540539
- Publisher
- Current Science Inc.
- Year
- 2010
- Tongue
- English
- Weight
- 191 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1540-3416
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Long-term efficacy and safety of deferas
β
Maria Domenica Cappellini
π
Article
π
2008
π
Elsevier Science
π
English
β 117 KB
The long-term efficacy and safety of new
β
Kim A. Papp
π
Article
π
2006
π
Springer-Verlag
π
English
β 258 KB
ENDEAVOR II β Long-Term Efficacy and Saf
π
Article
π
2007
π
Urban and Vogel
π
German
β 318 KB
Current Antiviral Therapy of Chronic Hep
β
Yuk-Fai Lam; Man-Fung Yuen; Wai-Kay Seto; Ching-Lung Lai
π
Article
π
2011
π
Current Science Inc.
π
English
β 176 KB
Long-term botulinum toxin efficacy, safe
β
Nicte I. Mejia; Kevin Dat Vuong; Joseph Jankovic
π
Article
π
2005
π
John Wiley and Sons
π
English
β 120 KB
## Abstract To determine the longβterm efficacy of botulinum toxin (BTX) treatments, we analyzed longitudinal followβup data on 45 patients (32 women; mean age, 68.8 years) currently followed in the Baylor College of Medicine Movement Disorders Clinic, who have received BTX treatments continuously
Efficacy of ipriflavone in established o
β
D. Agnusdei; L. Bufalino
π
Article
π
1997
π
Springer
π
English
β 533 KB